Literature DB >> 18154896

Opioid use in palliative care of children and young people with cancer.

Martin Hewitt1, Ann Goldman, Gary S Collins, Margaret Childs, Richard Hain.   

Abstract

OBJECTIVE: Identify opioids prescribed, preferred routes, and doses among children with incurable cancer. STUDY
DESIGN: Prospective survey with monthly questionnaires regarding patients 0 to 19 years old from oncology centers. Data were collected by professionals on each patient for 6 months or until death, and analyzed from patients who died. Impact of tumor was analyzed with Kruskal-Wallis and Mann-Whitney tests. Major opioid dosages are expressed as oral morphine equivalents.
RESULTS: Of 185 children recruited, 164 (88 boys, 76 girls) died. Mean palliative care duration was 67 days. One hundred forty-seven (89.6%) received major opioids. Morphine, diamorphine, and fentanyl were prescribed in 75%, 57.9%, and 11.6%, respectively. Seventy-three (44.5%) received >1 major opioid. Median monthly maximum doses prescribed rose from 2.1 mg/kg/24 h (study entry) to 4.4 mg/kg/24 h (death) (P < .001); overall variable (0.09-1500 mg/kg/24 h, median 3.7 mg/kg/24 h). Opioids were given by the oral (117/164, 71.3%), intravenous (68/164, 41.5%), subcutaneous (40, 28%), rectal (20, 12.2%), and transdermal (18, 11%) routes. There was a shift to intravenous use as death approached. Numbers within each tumor group were too small to show significance. Children with solid tumors outside the central nervous system were likely to receive more opioids, be given multiple different opioids, and receive opioids in the last month.
CONCLUSIONS: The study shows the United Kingdom practice of opioid use and provides comparator data for practice in children's palliative medicine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18154896     DOI: 10.1016/j.jpeds.2007.07.005

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Availability of palliative care services for children with cancer in economically diverse regions of the world.

Authors:  Eduardo Delgado; Raymond C Barfield; Justin N Baker; Pamela S Hinds; Jie Yang; Ayda Nambayan; Yuri Quintana; Javier R Kane
Journal:  Eur J Cancer       Date:  2010-06-10       Impact factor: 9.162

2.  Use of epidural and peripheral nerve blocks at the end of life in children and young adults with cancer: the collaboration between a pain service and a palliative care service.

Authors:  Doralina L Anghelescu; Lane G Faughnan; Justin N Baker; Jie Yang; Javier R Kane
Journal:  Paediatr Anaesth       Date:  2010-12       Impact factor: 2.556

3.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

Review 4.  Pediatric Oncology: Managing Pain at the End of Life.

Authors:  Jennifer M Snaman; Justin N Baker; Jennifer H Ehrentraut; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

5.  Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia.

Authors:  Kelly D Getz; Tamara P Miller; Alix E Seif; Yimei Li; Yuan-Shung V Huang; Brian T Fisher; Richard Aplenc
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 6.  Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.

Authors:  Jenny K W Lam; Chucky C K Cheung; Michael Y T Chow; Emily Harrop; Susie Lapwood; Stephen I G Barclay; Ian C K Wong
Journal:  Adv Drug Deliv Rev       Date:  2020-11-01       Impact factor: 15.470

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.